検索に戻る
案件記録

CONJUGATE COMPOUND COMPRISING 13-CIS-RETINOIC ACID AND ASCORBIC ACID

発明審査中
3閲覧数
7請求項 · 1 独立
§ Ⅰ

案件概要

IPC分類

C7D 307/62A61K 31/375A61P 35/

CPC分類

C7D307/62A61K31/375A61P35/

The present invention relates to a conjugate compound comprising 13-cis-retinoic acid and vitamin C, and its pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier. The present compound has a much better water solubility than that of retinoic acid, and thus reduces an effective dosage of retinoic acid and minimizes side effects. The present compound increases the efficiency and concentration of 13-cis-retinoic acid to cross the cell membrane into the cell. The present compound is useful in treating cancer such as pancreatic cancer.

原文(中国語)

The present invention relates to a conjugate compound comprising 13-cis-retinoic acid and vitamin C, and its pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier. The present compound has a much better water solubility than that of retinoic acid, and thus reduces an effective dosage of retinoic acid and minimizes side effects. The present compound increases the efficiency and concentration of 13-cis-retinoic acid to cross the cell membrane into the cell. The present compound is useful in treating cancer such as pancreatic cancer.

外部リソース